Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Amazon Releases Title, Plot Details Of Upcoming 'Lord Of The Rings' Series

Amazon.com, Inc. (NASDAQ: AMZN) has revealed the title and part of the storyline of its highly anticipated series based on J.R.R. Tolkien’s epic fantasy “The Lord of the Rings.”

Benzinga

Why China Finance Online Shares Are Falling

China Finance Online Co. (NASDAQ: JRJC) shares are trading lower after the company announced it has received a notice of delisting from Nasdaq.

Benzinga

The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Psychedelics Firm Eleusis Goes Public Via Merger With Silver Spike Acquisition Creating $450M Company

British psychedelics company Eleusis will go public via a merger with Silver Spike Acquisition Corp. II (“SPKB”) (NASDAQ: SPKB), a special purpose acquisition company sponsored by an affiliate of Silver Spike Capital.

Benzinga

10 Biggest Price Target Changes For Thursday

Piper Sandler cut Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $140 to $130. AMD shares fell 1.3% to $126.55 in pre-market trading.

Benzinga

21 Stocks Moving in Thursday's Pre-Market Session

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 36.2% to $0.2675 in pre-market trading. Baudax Bio, last month, announced a $4.2 million registered direct offering.

Benzinga

Here's Why Piper Sandler Downgraded AMD, Slashed Price Target By 7%

Piper Sandler analyst Harsh Kumar downgraded Advanced Micro Devices Inc (NASDAQ:AMD) to Neutral from Overweight with a price target of $130, down from $140. The analyst is cautious on the broader automotive sector, saying the pace of orders and strong pricing "may come into question" as supply normalizes in the second half of 2022. The…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

52 Biggest Movers From Yesterday

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion.

Benzinga

5 Stocks To Watch For January 20, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects American Airlines Group Inc. (NASDAQ: AAL) to report quarterly loss at $1.47 per share on revenue of $9.37 billion before the opening bell. American Airlines shares slipped 0.3% to $17.26 in pre-market trading.

Benzinga

FTSE 100 Live: Unilever shares rise as Glaxo interest cools, China cuts rates, Nasdaq in correction territory

The Nasdaq’s slide into “correction” territory after falling 10% since November today failed to unsettle the FTSE 100 index.

Evening Standard

Why Alibaba, Xpeng And Other Stocks Are Rising In Hong Kong Today

Shares of U.S.-listed Chinese tech companies traded mostly higher in Hong Kong on Thursday, lifting the benchmark Hang Seng Index to its highest level in almost two months.

Benzinga

ASX rallies as resources stocks boosted by China rate cut and higher commodity prices

The ASX pared its losses after miners and energy stocks rose after China cut interest rates again and the unemployment rate fell. The Nasdaq Composite index falls 10 per cent from its peak.

ABC News

2 New Titles For Netflix Games: What Investors Need To Know

Netflix Inc (NASDAQ: NFLX) announced Tuesday the company is expanding its mobile gaming lineup with the addition of two new games.

Benzinga

Why AMD Shares Fell Sharply This Week

Advanced Micro Devices, Inc. (NASDAQ: AMD) shares traded lower by 6.67% to $63.36 this week amid overall market weakness and a rise in the 10-year treasury yield, which is hovering around a decade high of 4%.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

6 Analysts Dissect Microsoft's Activision Blizzard Deal: 'A Call Option On Numerous Metaverse Plays'

Microsoft Corporation (NASDAQ: MSFT) announced Tuesday its biggest-ever acquisition by agreeing to buy Activision Blizzard, Inc.

Benzinga

Plug Power Drops Below A Key Support Level; Can Bulls Reenergize The Stock?

Plug Power Inc. (NASDAQ: PLUG) shares were trading lower Wednesday, dropping below a level that has held as support in the past. Breaking below support is a potentially bearish sign and shows buyers are not being found where they once were.

Benzinga

Fire & Flower Marijuana Retailer Prepares For NASDAQ Listing, Files 40-F With SEC

Marijuana retailer Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF) announced the filing of its Form 40-F Registration Statement with the US Securities and Exchange Commission (SEC) in preparation for the company to list its shares on the Nasdaq Stock Marke

Benzinga

35 Stocks Moving In Wednesday's Mid-Day Session

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Rimini Street Shares Gain On Roth Capital Upgrade

Roth Capital analyst Richard Baldry upgraded Rimini Street Inc (NASDAQ:RMNI) to Buy from Neutral with an $8 price target, suggesting an upside of 53%. The shares are down 57% versus their highs and trading at only 1.1-times run-rate revenues. The analyst does believe recent staccato growth results are likely to continue to temper a return…

Benzinga

Why This Tesla Analyst Is Projecting Sharp Drop In Market Share, Benefits For Legacy Automakers

Tesla, Inc. (NASDAQ: TSLA), which has a commanding position in the U.S. electric vehicle market, could see an erosion in market share in the medium term, according to a BofA Securities analyst.

Benzinga

ChemoCentryx's Avacopan Scores European Approval For ANCA-Associated Vasculitis

The European Union has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) for ANCA-associated vasculitis.

Benzinga

Stocks That Hit 52-Week Lows On Wednesday

During Wednesday's morning trading, 400 companies set new 52-week lows.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022

Upgrades

Benzinga

Why Zogenix Shares Are Soaring Today

Zogenix Inc (NASDAQ: ZGNX) is trading significantly higher Wednesday morning after the company announced it received a proposal to be acquired by UCB for approximately $1.9 billion.

Benzinga

Morgan Stanley Bumps Up Alphabet Price By 7.2%

Morgan Stanley analyst Brian Nowak raised the price target on Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) shares to $3,430 from $3,200 and reiterated an Overweight rating on the shares. The price target implies an upside of 25.8%. Nowak updated his models and rolled forward valuations among his Internet sector coverage. Heading into 2022, Nowak said he remains…

1 … 822 823 824 825

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.